The Department of Physiotherapy, University College of Northern Denmark
Aalborg, 9210, Denmark
NCT Number: NCT05015946
This single-arm pilot study aims to investigate the feasibility of a handball-based intervention to people diagnosed with type 2 diabetes, including monitoring aerobic intensities and movement strategies during the intervention, and monitoring recruitment, adherence, and adverse events.
Furthermore, the study aims to investigate the feasibility of a test battery including both physiological and patient-reported outcomes, and to investigate preliminary exercise effects.
Looking for future studies?
Notify Me30 year and older
All sexes
Interventional
Not applicable
Aalborg, 9210, Denmark
Physical activity and exercise are known to be beneficial for increasing insulin sensitivity in skeletal muscle in healthy as well as in individuals with type 2 diabetes. But many patients who recently have been diagnosed with type-2 diabetes is often living a sedentary lifestyle and have poor adherence to physical interventions.
High intensity interval training as well as team-based interventions has proven to be effectful in regulation of physiological parameters related to type 2 diabetes. The aim of this study is to investigate the feasibility of a handball-based intervention to people diagnosed with type 2 diabetes
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
60 minutes small-sided team handball training. Initial 20 minutes of warm-up including exercises for strength, aerobic, balance, coordination, and mobility. Hereafter 20 minutes of handball specific exercises including dribbling, running and shooting. Final 20 minutes of small-sided handball matches.
Time frame: change from baseline to 12 weeks
HbA1c measured with HemoCue HbA1c 501
Time frame: change from baseline to 12 weeks
Peak oxygen uptake measured with incremental cycling test
Time frame: change from baseline to 12 weeks
Health related quality of life measured with the danish version of Short Form 36 (SF-36)
Time frame: change from baseline to 12 weeks
Total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL) measured with Accutrend Plus Cholesterol Meter
Time frame: change from baseline to 12 weeks
Body mass index measured by kg/M2
Time frame: change from baseline to 12 weeks
Total body fat in kg measured with Tanita MC-180MA, Tokyo, Japan
Time frame: change from baseline to 12 weeks
Lean body mass in kg measured with Tanita MC-180MA, Tokyo, Japan
Time frame: change from baseline to 12 weeks
Visceral adipose tissue measured with hip (widest part of the hip) and waist (2.5 cm above the navel) ratio.
Time frame: change from baseline to 12 weeks
Blood pressure and resting puls measured with an automatic upperarm blood pressure monitor
Time frame: change from baseline to 12 weeks
Aerobic endurance measured with Intermittent Recovery Test Level 1
Time frame: change from baseline to 12 weeks
Self-care behavior measured with diabetes Intention, Attitude, and Behavior Questionnaire (DIAB-Q)
Time frame: change from baseline to 12 weeks
Physical activity scale (PAS)
Time frame: measured during intervention in week 2,3,6,7,10 and 11.
Aerobic intensities (percent of maximal heart rate) measured with pulse monitor, and movement patterns (Metabolic Equivalent of Task (MET)) measured with accelerometer.
University College of Northern Denmark
Other
Handball-based Exercise for People Diagnosed With Type 2 Diabetes: a Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03653091
Diabetes Mellitus, Diabetes Mellitus, Type 2
Orlando, Florida, United States
View Trial DetailsNCT01841697
Diabetes Mellitus, Diabetes Mellitus, Type 2
View Trial DetailsNCT02316821
Chronic Disease, Chronic Kidney Disease
Tokyo, Japan
View Trial DetailsNCT01137474
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial Details